{"id":"W1977237795","doi":"10.1158/1535-7163.targ-09-a55","title":"Abstract A55: A first-in-human, phase I study of an oral hedgehog pathway antagonist, BMS-833923 (XL139), in subjects with advanced or metastatic solid tumors","year":2009,"lang":"en","type":"article","venue":"Molecular Cancer Therapeutics","topic":"Hedgehog Signaling Pathway Studies","field":"Biochemistry, Genetics and Molecular Biology","cited_by":16,"is_retracted":false,"has_abstract":true,"ca_institutions":"Princess Margaret Cancer Centre","funders":"","keywords":"Medicine; Tolerability; Pharmacodynamics; Pharmacokinetics; Dosing; Cohort; Internal medicine; Pharmacology; Oncology; Gastroenterology; Adverse effect","routes":{"ca_aff":true,"ca_fund":false,"ca_venue":false,"about_ca":false,"invisible_to_affiliation_only":false},"retraction":null,"screen":null,"direct_labels":[],"prediction":{"model_version":"metacan-v3-hybrid-931329e0061c","candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.001114962,0.001654191,0.001563496,0.0004069436,0.0005197845,0.0009558717,0.0007559306,0.0009149183,0.005098708],"category_scores_gemma":[0.0005424173,0.0006244254,0.001250149,0.0003014938,0.0007964867,0.0006604081,0.000280934,0.002704448,0.001397789],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.0007485632,"about_ca_system_score_gemma":0.001451362,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.001687849,"about_ca_topic_score_gemma":0.00378424,"domain_scores_codex":[0.9996327,0.0001305393,0.00002836536,0.00008228644,0.00004461727,0.00008147953],"domain_scores_gemma":[0.9995037,0.00006020392,0.00007539433,0.00004286186,0.00003914956,0.0002786139],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"randomized_trial","study_design_gemma":"nonrandomized_trial","study_design_scores_codex":[0.4915066,0.1273516,0.0149185,0.001483971,0.003022208,0.0008513745,0.0005757788,0.002232775,0.2258501,0.0003882912,0.009640192,0.1221786],"study_design_scores_gemma":[0.3394175,0.6180347,0.02659784,0.00003665116,0.0008367579,0.0004738163,0.00007666891,0.001036687,0.01021564,0.0001308831,0.003106958,0.00003591088],"study_design_candidate":"nonrandomized_trial","study_design_consensus":null,"genre_codex":"empirical","genre_gemma":"empirical","genre_scores_codex":[0.9930153,0.001452051,0.000630133,0.0002456327,0.0000922782,0.001837082,0.001141992,0.0001264055,0.001459119],"genre_scores_gemma":[0.9904357,0.001202628,0.001486241,0.0006662365,0.0001423957,0.001144389,0.001822629,0.00003099098,0.00306875],"genre_candidate":"empirical","genre_consensus":"empirical","teacher_disagreement_score":0.005098708,"threshold_uncertainty_score":0.01705682,"prediction_status":"machine_predicted_unvalidated"},"machine_scores":{"provisional":true,"baseline":true,"maturity_gate_passed":false,"score_opus":0.03588005930201919,"score_gpt":0.3498965638264837,"score_spread":0.3140165045244644,"validation_status":"score_only:v0-immature-baseline","note":"Baseline scores from an immature model (maturity gate not passed). Scores rank; they never assert a category."}}